Emergent BioSolutions Inc (EBS)

10.09 -0.19 (-1.85%) USD  |  NYSE  |  Jan 08, 16:00
9.91 -0.18 (-1.78%) After-Hours: 20:00
More

Emergent BioSolutions Cash and Short Term Investments (Annual): 111.70M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Abbott Laboratories 7.279B
Tonix Pharmaceuticals Holding Corp 24.95M
Chimerix Inc 182.84M
Marinus Pharmaceuticals Inc 150.29M
MAIA Biotechnology Inc 7.151M